ENSYSCE BIOSCIENCES, INC. Accounts Payable
ENSYSCE BIOSCIENCES, INC. (ENSC) had Accounts Payable of $1.98 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-13
- 2026-06-30: Accounts Payable, Current $1.98M.
- 2026-03-31: Accounts Payable, Current $1.61M.
- 2025-12-31: Accounts Payable, Current $3.27M.
- 2025-09-30: Accounts Payable, Current $463.46K.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $1.98M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $1.61M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $3.27M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $463.46K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $1.04M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $615.29K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $1.36M 10-K · filed 2026-03-30 |
| 2024-09-30 | $1.97M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $481.97K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $981.72K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $1.94M 10-K · filed 2025-03-10 |
| 2023-09-30 | $916.42K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $1.27M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $1.60M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $2.94M 10-K · filed 2024-03-15 |
| 2022-09-30 | $1.29M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $3.05M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $959.63K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $301.10K 10-K · filed 2023-03-30 |
| 2021-09-30 | $471.86K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $3.14M 10-Q · filed 2021-08-16 |
| 2020-12-31 | $1.72M 10-K · filed 2022-03-31 |
| 2020-09-30 | $326.43K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $163.69K 10-Q · filed 2020-08-07 |
| 2020-03-31 | $3.49M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $2.77M 10-Q · filed 2020-11-09 |
| 2019-09-30 | $1.13M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $745.55K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $341.55K 10-Q · filed 2019-05-07 |
| 2018-12-31 | $429.25K 10-K · filed 2020-03-10 |
| 2018-09-30 | $350.17K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $126.60K 10-Q · filed 2018-08-01 |
| 2018-03-31 | $72.04K 10-Q · filed 2018-05-03 |
| 2017-12-31 | $111.96K 10-K/A · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |